On international Women Human Rights Defenders Day, FIGO stands with partners and allies to support the launch a new set of ...

FIGO’s Self-Management of Abortion (SMA) Project, which concluded in May 2024, worked to implement WHO Abortion Guideline on ...

FIGO’s Improving access to essential medicines to reduce postpartum haemorrhage (PPH) morbidity and mortality (IAP) project ...

"This protocol represents a significant step forward in standardising care for women recovering from vesicovaginal fistula ...

FIGO’s Combatting Post-Partum Hemorrhage (PPH) project aims to provide technical support to selected regional and national ...

FIGO and the World Health Organization (WHO) are collaborating to enhance family planning care globally, by increasing ...

This World Prematurity Day, FIGO calls on healthcare providers, policymakers, and communities to champion better care for ...

Postpartum Haemorrhage (PPH) is the leading cause of maternal mortality in low-income countries. The most common cause of PPH ...

FIGO’s Accelerating Measurable Progress and Leveraging Investments for Postpartum Haemorrhage Impact (AMPLI-PPHI) project ...

Project leads: Professor Sean Kehoe, Past Chair and current member of the FIGO Committee on Women's Cancer; Professor Joanna ...

Background: Post-partum haemorrhage (PPH) is the most significant direct cause of maternal mortality in low-resource ...

The key goal of the FIGO Saving Mothers and Newborns Initiative was to contribute to the reduction in maternal and newborn ...